A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson’s patients, according to results of a Phase 2 study published today in the journal Lancet Neurology. The approach introduces a gene into the brain to normalize chemical signaling.
Since 1900, the percentage of Americans aged 65 years and older has tripled, largely due to advancements in technology and lifestyle changes. These statistics are important when considering the future of health and health care in the United States. As such, every effort should be made to continue identifying disparities in health and health care and effective methods to eliminate them. It has become ever more important to not only research and effectively address health disparities prevalent in the elderly population, but also to train the next generation of health care providers to care specifically for this particular demographic.